{
    "study_accession": "SDY194",
    "actual_completion_date": "2012-01-02",
    "actual_enrollment": 120,
    "actual_start_date": "2011-01-03",
    "age_unit": "Years",
    "brief_description": "Innate Immune Pathways in Elderly and Immunosuppressed Populations",
    "brief_title": "Innate Immune Pathways in Elderly and Immunosuppressed Populations 2011",
    "clinical_trial": "N",
    "condition_studied": "Aging, immunosuppression (Rheumatoid Arthritis)",
    "dcl_id": 2,
    "description": "Innate Immune Pathways in Elderly and Immunosuppressed Populations",
    "doi": "10.21430/M32GW683ZT",
    "endpoints": "Enrollment of sufficient subjects to achieve statistically significantly experimental results.",
    "gender_included": "Not Specified",
    "hypothesis": "Age, functional status as manifested by frailty, and immunosuppressive medications will alter Nod-like receptor (NLR) and/or Rig-I like receptor (RLR) function.",
    "initial_data_release_date": "2017-09-29",
    "initial_data_release_version": "DR23",
    "intervention_agent": "Influenza vaccine",
    "latest_data_release_date": "2017-09-29",
    "latest_data_release_version": "DR23",
    "maximum_age": "  89.00",
    "minimum_age": "  21.00",
    "objectives": "Define consequences of aging, functional status, and immunosuppression on NLR and RLR expression and function. Define mechanisms of immune dysregulation that reduce vaccine responsiveness and resistance to infection.",
    "official_title": "Innate Immune Pathways in Elderly and Immunosuppressed Populations",
    "sponsoring_organization": "NIAID",
    "target_enrollment": 120,
    "workspace_id": 2550,
    "research_focus": [
        "Vaccine Response"
    ],
    "arm": [
        {
            "arm_accession": "ARM835",
            "description": "Young adults 21-30 years old",
            "name": "Young"
        },
        {
            "arm_accession": "ARM836",
            "description": "Older adults >= 65 years old",
            "name": "Old"
        },
        {
            "arm_accession": "ARM837",
            "description": "Individuals age > 21 with Rheumatoid Arthritis (RA) who satisfy the 1987 American College of Rheumatology revised criteria for RA",
            "name": "Immunosuppressed"
        }
    ],
    "personnel": [
        {
            "first_name": "Erol",
            "last_name": "Fikrig",
            "organization": "Yale",
            "role_in_study": "Principal Investigator",
            "site_name": "Yale"
        }
    ],
    "pubmed": [],
    "program": [
        {
            "program_name": "Protective Immunity in Special Populations",
            "contract_name": "Innate Immune Pathways in Elderly and Immunosuppressed Populations SP2 Yale"
        }
    ],
    "assay": [
        {
            "measurement_technique": "Flow Cytometry",
            "number_of_expsamples": 445
        },
        {
            "measurement_technique": "Hemagglutination Inhibition",
            "number_of_expsamples": 155
        },
        {
            "measurement_technique": "Q-PCR",
            "number_of_expsamples": 6
        }
    ],
    "subject": {
        "race": [
            {
                "race": "Asian",
                "count": 11
            },
            {
                "race": "Black or African American",
                "count": 8
            },
            {
                "race": "Other",
                "count": 1
            },
            {
                "race": "Unknown",
                "count": 1
            },
            {
                "race": "White",
                "count": 99
            }
        ],
        "gender": [
            {
                "Female": 75
            },
            {
                "Male": 45
            }
        ]
    }
}
